We report first description of clinical cases of 
Background
The development of resistance to carbapenems as the last available therapy line of antimicrobials represents a special concern issue in infectious diseases. Carbapenemases -producing Enterobacteriaceae (CPE) are sometimes difficult to detect even with the new breakpoints of EUCAST and CLSI. It is important to confirm the presence of carbapenemase genes by PCR techniques in order to implement interventions which can avoid potential serious hospital epidemics. There are 3 classes of carbapenemases: class A (KP carbapenemases -KPC), class B (metallo-betalactamases -MBLs) and class D oxacillinases (among them OXA-48-like enzymes) (1) . The presence of OXA-48-like producing CPE was initially reported as endemic in Turkey, Northern Africa and Middle East (2-5) but more recently several other countries signaled sporadic cases and/or epidemic evolution in several surveillance studies, especially in the USA, India and some European countries (6) (7) (8) (9) (10) .
In October 2011 ECDC initiated a communication of risk assessment for CPE importation in Europe related to Libyan patients transferred to European hospitals (11) . Slovenian colleagues communicated in December 2011 the first case of OXA-48 K pneumoniae colonization in a hospitalized patient (12) . In 2012 several Libyan patients were transferred to Bucharest hospitals; being concerned of the difficulty to identify carbapenem resistant Enterobacteriaceae (CRE) testing for antimicrobial susceptibility with panels adapted from the older clinical breakpoints of CLSI, we initiated a cooperative study with AGES (Austrian Agency for Public Health and Food Safety). The work included the characterization of K. pneumoniae isolates. Among all strains of K. pneumoniae isolated in our hospital during the four months period (December 2012-March 2013), we identified by testing with semi-automated methods (MicroScan or Vitek) a number of 18 strains having 3 rd generation cephalosporin resistance and a positive modified Hodge test. In accordance with CLSI 2010 breakpoints (still in use in our hospital in the first months of 2013), these testing panels indicated imipenem susceptibility as CMI ≤ 4 mg/L. The isolates were sent to AGES in order to perform the detection of ESBL and carbapenemases production. Multiplex-PCR amplifications were carried out for the detection of genes encoding the extended spectrum betalactamases, including TEM, SHV, OXA (multiplex assay), CTX-M-1, -2, -9 (multiplex assay), OXA-48 carbapenemase (singleplex assay) and carbapenemase genes VIM and KPC (multiplex assay) with primers previously described (13) . Plasmid-mediated AmpC β-lactamase gene clusters FOX, ACC, CIT, DHA, MOX, EBC were detected in a multiplex assay (AmpC) using primers previously described (14) . All isolates exhibit several beta-lactamases production and four isolates were OXA-48 positive. No KPC-producing isolates were retrieved. (Table 1).
We studied the clinical history of these four patients in order to describe the common findings and to identify patients with increased risk of OXA-48-producing K.pneumoniae infection or colonization ( Table 2 ).
The first case
In December 2012 a 76 year-old woman was admitted in "Matei Bals" National Institute of Infectious Diseases (MB-NIID) for the treatment of a post-surgery infection presumed to be produced by methicillin resistant Staphylococcus aureus (MRSA). The patient had been diagnosed with recto-sigmoid adenocarcinoma in august 2012 with a single liver metastasis. After two weeks, a Hartman's procedure and also liver metastasis resection were performed. After another two weeks, an intraabdominal collection was found and a second surgical intervention was performed. Because a persistent purulent secretion was observed from the surgical wound she was admitted in our hospital. At the admission, the patient was afebrile, without systemic inflammatory response syndrome (SIRS), with normal vital signs, without pulmonary, cardiac or intraabdominal signs of infection and with a purulent secretion from the surgical wound. A strain of MRSA from the purulent secretion was isolated in the department of surgery at Fundeni Hospital and the patient received anti-MRSA therapy with the persistence of symptoms. In our hospital, two germs were isolated from wound: a MRSA strain and also a K.pneumoniae strain with extended spectrum betalactamases (ESBL), resistant to ertapenem, penicillin plus betalactamases inhibitors (BLI), cephalosporins, fluoroquinolones, trimethoprim/sulfamethoxazole (TMP/SMX) and aminoglycosides. The strain was characterized as susceptible to imipenem, meropenem and colistin. The patient received therapy with imipenem and vancomycin for 14 days with slow favorable outcome and wound healing.
The second case
In December 2012 a 92 year-old woman was admitted in MB-NIID for the treatment of a post-antibiotic Clostridium difficile diarrhea. The patient had been diagnosed with left ure- 
The third case
In February 2013, an 85 year-old male, known with type 2 diabetes mellitus treated with insulin, chronic kidney disease, cardiac insufficiency and chronic anemia was admitted in our hospital for fever, chills, disorientation, dyspnea and tachypnea. The patient had received medical services repeatedly in the past six months (including in a surgery ward) and urinary catheterization was performed during the previous hospitalization. In December 2012, during a coronary ICU hospitalization, he developed two episodes of urinary tract infection: the first with K. pneumoniae without ESBL (treated with ceftriaxone) and the second one with Pseudomonas aeruginosa resistant to carbapenems (treated with levofloxacin and colistin). At the admission in our hospital the patient had SIRS: fever, tachycardia, tachypnea and leukocytosis, normal arterial blood pressure, without evidence of organ insufficiency, with symptoms of urinary tract infection: dysuria, polakiuria and hypogastric pain. The antimicrobial therapy was empirically initiated with ceftriaxone and levofloxacin. After 48 hours, a strain of K. pneumoniae ESBL-producing was isolated from blood-culture and urine-culture, susceptible to colistin, imipenem and TMP/SMX and resistant to third generation cephalosporins, ertapenem and penicillin-BLI's. The antimicrobial therapy switched to colistin and TMP/SMX with dosage adapted to creatinine clearance for 12 days with good outcome. The patient was discharged after 15 days.
The fourth case
In March 2013, a 67 year-old female who underwent a hemicolectomy for cecum carcinoma, developed fever, chills, tachycardia and tachypnea during the ICU postoperative period. A blood-culture was performed and an ESBL-producing strain of K. pneumoniae was isolated. This strain was resistant to: carbapenems (both ertapenem and imipenem), penicillin -BLI, cephalosporins, fluoroquinolones, aminoglycosides and colistin. The strain was sensitive only to TMP/SMX. The patient received TMP/SMX with unfavorable outcome and died after 5 days.
Discussion
Organism identification and susceptibility testing were performed for all the strains using semiautomatic methods (VITEK 2,-BioMerieux, Mercy L'Etoile, France and MicroScan, West Sacramento, CA, USA). The interpretation of results was made according to CLSI 2010 rules. E-tests were used for colistin. (Table 3) .
Class D betalactamases, named oxacillinases (OXA), were initially associated with Acinetobacter baumannii strains. Although at the beginning Enterobacteriaceae strains were not associated with this type of carbapenemases, OXA-48 and related variants emerged in Enterobacteriaceae. OXA-48 producing K. pneumoniae is difficult to detect because these strains weakly hydrolyze carbapenems, some broad-spectrum cephalosporins, such as ceftazidime and cefepime, and aztreonam. (2) All the described strains were resistant to third and fourth generation cephalosporins, probably due to associated production of oxacillinases and ESBL. The MIC value for carbapenems is also higher in OXA-48 producers when an ESBL production is associated. (15) Several articles published in the last years signaled the presence of OXA-48 K. pneumoniae isolates starting with 2010 in patients admitted in hospitals from different cities in Romania (16) (17) (18) (19) . We described the first cases of OXA-48 K. pneumoniae infections diagnosed in our hospital. All cases were admitted in surgical wards and underwent some surgical procedure. In three cases, broad spectrum antimicrobial therapy was necessary. None of the patients had any history of carbapenem exposure prior to the detection of OXA-48 KP.
The Hodge modified test could be useful to detect OXA-48 KP producers. The rectal screening of all patients for CRE could be negative even in patients colonized with such a bacteria. However, rectal screening for CRE must continue in all areas where this CPE emergence was described.
The data presented in this article had some limitations. First of all this is a case series presentation and we did not perform a study with 
Colistin (E-test) .38 S .5 S 2 S 4 R a well-established design. We started with the identification of OXA-48 K. pneumoniae strains and then we analyzed the patients. Another limitation was the absence of molecular epidemiology analysis of cases filiation.
In conclusion, the emergence of CRE in Romania after 2010, highlighted the importance of antimicrobial resistance surveillance especially in countries with limited resources. The molecular characterization can ensure an early recognition of CRE. It seems reasonable that first CRE strains including OXA-48 K. pneumoniae were imported before 2010 in Romania from endemic areas: United States, Greece and Israel for KPCs, Turkey for OXA-48 K. pneumoniae, India for NDMs and Greece for VIMs. (15, 20) . However, our case reports suggest that in 2012-2013 already existed a risk for the patients to be colonized with such strains in Romanian hospitals. It is therefore important to improve both infection control practice and antimicrobial stewardship in order to limit CRE spread in Romania.
